Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The African Malaria Network Trust (AMANET) was a pan-African non-profit organization headquartered in Tanzania that played a central role in malaria vaccine research and development. Established in 2002 as a successor to the African Malaria Vaccine Testing Network, the Trust focused on building African capacity to conduct high-quality, ethically sound clinical trials. AMANET provided essential services including Good Clinical Practice (GCP) training, ethical review support, and infrastructure development for research sites across the continent. The organization was a key facilitator for multi-center clinical trials for major vaccine candidates, most notably the RTS,S/AS01 malaria vaccine. By coordinating efforts between international sponsors and African researchers, AMANET ensured that clinical evaluations of malaria interventions were led by local scientists to address regional health priorities. Although it is no longer actively managing new programs, its contributions were foundational to the successful development of the first WHO-approved malaria vaccine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on African Malaria Network Trust.